Pharmaceutical Preparations Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Pharmaceutical Preparations
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

M
2018-04-19
SPPISpectrum Pharmaceuticals IncShrotriya Rajesh C MdDirS - Sale$18.74-90,0004,397,029-2%-$1,686,600
DM
2018-04-19
CERCCerecor Inc.Armistice Capital, LLCDir, 10%P - Purchase$3.76+20,00032,440,0000%+$75,146
M
2018-04-19
AKAOAchaogen IncDuggan Robert W10%P - Purchase$13.06+468,3377,023,076+7%+$6,118,654
2018-04-19
AMARAmarillo Biosciences IncChen Stephen TPres, CEO, COB, 10%P - Purchase$0.22+1,0005,463,7410%+$220
2018-04-19
COLLCollegium Pharmaceutical, IncHeffernan Michael ThomasCOB, Pres, CEOS - Sale$26.00-44,400545,793-8%-$1,154,401
D
2018-04-23
SURFSurface Oncology, Inc.Novartis Institutes For Biomedical Research, Inc.10%P - Purchase$15.00+766,6663,948,482+24%+$11,499,990
2018-04-19
RDUSRadius Health, Inc.Biotech Growth N V10%P - Purchase$33.80+40,0006,050,913+1%+$1,351,936
2018-04-20
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$3.12+60,000190,519,8830%+$187,490
AM
2018-04-18
CNABUnited Cannabis CorpBlackmon EarnestPres, CEO, 10%S - Sale$1.05-163,11721,474,493-1%-$171,602
D
2018-04-19
FGENFibrogen IncRosenkranz Roberto PedroDirS - Sale+OE$47.70-1,00029,000-3%-$47,700
D
2018-04-19
FGENFibrogen IncKurkijarvi KaleviDirS - Sale+OE$47.69-4,00020,000-17%-$190,760
M
2018-04-18
EYEGEyegate Pharmaceuticals IncArmistice Capital, LLC10%P - Purchase$0.49+2,534,47832,493,956+8%+$1,231,159
M
2018-04-18
CNABUnited Cannabis CorpBlackmon EarnestPres, CEO, 10%S - Sale$1.05-163,11721,474,493-1%-$171,602
DM
2018-04-18
SUPNSupernus Pharmaceuticals IncVaughn VictorSVP of Sales, MarketingS - Sale+OE$47.93-17,8509,344-66%-$855,472
2018-04-19
ATNMActinium Pharmaceuticals, Inc.Seth SandeshCOB, CEOP - Purchase$0.38+5,000133,333+4%+$1,900
2018-04-18
KERXKeryx Biopharmaceuticals IncCarberry Christine A.COOS - Sale$4.83-2,026115,176-2%-$9,786
D
2018-04-18
KPTIKaryopharm Therapeutics Inc.Shacham SharonPres, CSOS - Sale+OE$14.79-10,0001,320,271-1%-$147,878
D
2018-04-18
KPTIKaryopharm Therapeutics Inc.Kauffman MichaelCEOS - Sale+OE$14.79-10,0001,320,271-1%-$147,878
2018-04-19
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$3.17+10,000190,459,8830%+$31,700
DM
2018-04-17
FGENFibrogen IncNeff Thomas BCEOS - Sale+OE$48.56-39,6363,101,609-1%-$1,924,630
D
2018-04-17
BMRNBiomarin Pharmaceutical IncLawlis V BryanDirS - Sale+OE$85.00-3,75014,860-20%-$318,750
2018-04-17
AKCAAkcea Therapeutics, Inc.Ionis Pharmaceuticals Inc10%P - Purchase$18.75+10,666,66664,114,545+20%+$199,999,988
2018-04-18
ANIPAni Pharmaceuticals IncMarshbanks TracyDirS - Sale$62.09-33,200450,601-7%-$2,061,388
M
2018-04-17
ALRNAileron Therapeutics IncApple Tree Partners II LP10%S - Sale$6.31-107,9041,541,682-7%-$681,390
2018-04-17
FOLDAmicus Therapeutics IncDo HungChief Science OfficerS - Sale$15.00-50,000446,771-10%-$750,000
M
2018-04-17
SNNASienna Biopharmaceuticals, Inc.Harris ToddHead of Corporate DevelopmentS - Sale$20.08-18,011572,066-3%-$361,619
D
2018-04-18
VRTXVertex Pharmaceuticals Inc / MaSilva Paul MSVP, Corp ControllerS - Sale+OE$166.05-85916,256-5%-$142,637
D
2018-04-17
IONSIonis Pharmaceuticals IncCrooke Stanley TCOB, CEOS - Sale+OE$44.40-13,962781,252-2%-$619,913
D
2018-04-17
EBSEmergent Biosolutions Inc.Richard RonaldDirS - Sale+OE$55.00-7,89323,410-25%-$434,115
M
2018-04-17
SAGESage Therapeutics, Inc.Starr Kevin PDirS - Sale$168.85-59,000340,179-15%-$9,962,250
2018-04-17
CNCEConcert Pharmaceuticals, Inc.Cassella James VChief Development OfficerS - Sale$20.18-10,58230,000-26%-$213,510
D
2018-04-17
GBTGlobal Blood Therapeutics, Inc.Choi JungSee RemarksS - Sale+OE$45.50-3,000162,677-2%-$136,500
M
2018-04-17
CNABUnited Cannabis CorpVerzura TonyVP, 10%S - Sale$1.16-97,05013,148,115-1%-$112,882
2018-04-16
FGENFibrogen IncYu K PeonyChief Medical OfficerS - Sale$47.81-7,500152,833-5%-$358,553
D
2018-04-16
NKTRNektar TherapeuticsThomsen Jillian B.SVP, Chief Accounting OfficerS - Sale+OE$101.46-13,88168,857-17%-$1,408,366
D
2018-04-16
FOLDAmicus Therapeutics IncRaab MichaelDirS - Sale+OE$14.41-5,0005,814-46%-$72,058
M
2018-01-16
MDCOMedicines Co /deKessler Armin MDirS - Sale$28.71-20,000130,993-13%-$574,200
DM
2018-04-16
CERCCerecor Inc.Armistice Capital, LLCDir, 10%P - Purchase$3.42+150,00032,400,0000%+$512,373
D
2018-04-16
ENTAEnanta Pharmaceuticals IncAdda NathalieSVP, Chief Medical OfficerS - Sale+OE$85.58-4,2256,000-41%-$361,560
D
2018-04-16
ARNAArena Pharmaceuticals IncSpector Steven WEVP, GC, SecS - Sale+OE$34.57-30,00119,690-60%-$1,037,058
D
2018-04-17
EYEGEyegate Pharmaceuticals IncGaranzini MichaelChief Commercial OfficerP - Purchase$0.00+156,250171,250>999%+$0
D
2018-04-17
EYEGEyegate Pharmaceuticals IncFrom StephenPres, CEOP - Purchase$0.00+125,000409,820+44%+$0
D
2018-04-17
EYEGEyegate Pharmaceuticals IncRomano SarahCFOP - Purchase$0.00+62,500106,863+141%+$0
2018-04-16
JAZZJazz Pharmaceuticals PlcYoung Matthew P.EVP, CFOS - Sale$156.01-70038,465-2%-$109,207
2018-04-16
ANABAnaptysbio IncLydon NicholasDirS - Sale$86.88-33,000271,106-11%-$2,866,913
2018-04-17
SPPISpectrum Pharmaceuticals IncTurgeon Joseph W.CEO, PresS - Sale$19.00-11,565316,509-4%-$219,751
M
2018-04-16
SPPISpectrum Pharmaceuticals IncShrotriya Rajesh C MdDirS - Sale$19.00-90,0004,487,029-2%-$1,709,700
D
2018-04-18
ARRYArray Biopharma IncVan Lunsen Gil JDirS - Sale+OE$15.19-21,50019,297-53%-$326,585
D
2018-04-16
GALTGalectin Therapeutics IncZucconi Theodore DanielDirS - Sale+OE$3.58-4,0001,083-79%-$14,320
D
2018-04-16
VRTXVertex Pharmaceuticals Inc / MaArbuckle Stuart AEVP\Chief Commercial OfficerS - Sale+OE$163.01-2,12546,892-4%-$346,396
M
2018-04-13
AMARAmarillo Biosciences IncChen Stephen TPres, CEO, COB, 10%P - Purchase$0.21+7,0005,462,7410%+$1,453
DM
2018-04-13
EYEGEyegate Pharmaceuticals IncArmistice Capital, LLC10%P - Purchase$0.36+10,479,97027,425,000+62%+$3,740,050
M
2018-04-16
SPPISpectrum Pharmaceuticals IncRiga Thomas JEVP, COO, CCOS - Sale$18.75-5,740250,778-2%-$107,603
2018-04-16
MRKMerck & Co., Inc.Graddick Weir Mirian MExe V-P, HRS - Sale$58.00-24,00080,433-23%-$1,392,000
M
2018-04-12
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPres, 10%P - Purchase$0.04+10,00024,954,7890%+$358
M
2018-04-13
LLYLilly Eli & CoMahony SusanSVP, Pres, Lilly OncologyS - Sale$80.09-22,54446,612-33%-$1,805,633
2018-04-16
CNABUnited Cannabis CorpVerzura TonyVP, 10%S - Sale$1.24-12,26213,245,1650%-$15,178
D
2018-04-16
GTHXG1 Therapeutics, Inc.Velleca Mark A.Pres, CEOS - Sale+OE$36.00-7,5000-100%-$269,971
D
2018-04-16
GTHXG1 Therapeutics, Inc.Malik RajeshCh. Medical Officer, SVP R, DS - Sale+OE$36.05-3,7764,200-47%-$136,135
2018-04-16
TORCRestorbio, Inc.Schor ChenPres, CEOP - Purchase$8.95+2,0001,892,3630%+$17,907
2018-04-16
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$3.02+50,000190,449,8830%+$150,950
2018-04-16
OPKOpko Health, Inc.Fishel Robert ScottDirP - Purchase$3.01+15,0004,036,4280%+$45,100
D
2018-04-12
FOLDAmicus Therapeutics IncBarth JayChief Medical OfficerS - Sale+OE$14.72-5,00085,534-6%-$73,602
D
2018-04-12
AGIOAgios Pharmaceuticals IncBowden ChristopherChief Medical OfficerS - Sale+OE$85.09-2,000881-69%-$170,190
2018-04-13
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$2.99+30,000190,399,8830%+$89,800
2018-04-13
OPKOpko Health, Inc.Fishel Robert ScottDirP - Purchase$3.02+10,0004,021,4280%+$30,200
D
2018-04-10
BDSIBiodelivery Sciences International IncSirgo Mark ADirS - Sale+OE$2.06-100,0002,499,542-4%-$206,000
2018-04-13
JAZZJazz Pharmaceuticals PlcMiller Michael PatrickEVP, US CommercialS - Sale$157.49-20027,481-1%-$31,498
M
2018-04-11
SPPISpectrum Pharmaceuticals IncShrotriya Rajesh C MdDirS - Sale$20.32-90,0004,577,029-2%-$1,828,500
2018-04-12
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$3.04+65,000190,369,8830%+$197,300
D
2018-04-11
MYOKMyokardia IncBauer JakeSee RemarksS - Sale+OE$50.00-5,00061,777-7%-$250,000
2018-04-10
SNNASienna Biopharmaceuticals, Inc.Harris ToddHead of Corporate DevelopmentS - Sale$20.02-3,779590,077-1%-$75,641
D
2018-04-10
NKTRNektar TherapeuticsHora ManinderSVP Pharma Dev, Mfg OpsS - Sale+OE$105.67-50280,261-1%-$53,046
2018-04-10
BHVNBiohaven Pharmaceutical Holding Co Ltd.Berman RobertChief Medical OfficerS - Sale$24.66-35,000959,050-4%-$863,132
2018-04-10
JAZZJazz Pharmaceuticals PlcWilson Karen JSVP, Finance, PAOS - Sale$155.00-3,89919,517-17%-$604,345
M
2018-04-09
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPres, 10%P - Purchase$0.04+5,10024,944,7890%+$195
2018-04-11
TORCRestorbio, Inc.Schor ChenPres, CEOP - Purchase$9.36+2,0001,890,3630%+$18,724
2018-04-11
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$3.06+43,000190,304,8830%+$131,727
D
2018-04-09
FGENFibrogen IncRoutti JormaDirS - Sale+OE$46.59-6,000127,840-4%-$279,554
M
2018-04-09
CNABUnited Cannabis CorpBlackmon EarnestPres, CEO, 10%S - Sale$0.83-200,00021,637,610-1%-$165,746
D
2018-04-09
UTHRUnited Therapeutics CorpRothblatt Martine ACOB, CEOS - Sale+OE$110.88-21,513683,795-3%-$2,385,368
2018-04-10
TORCRestorbio, Inc.Schor ChenPres, CEOP - Purchase$8.46+2,0001,888,3630%+$16,915
2018-04-10
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$3.06+36,527190,261,8830%+$111,706
M
2018-04-06
SPPISpectrum Pharmaceuticals IncShrotriya Rajesh C MdDirS - Sale$16.79-45,9864,667,029-1%-$772,113
2018-04-09
PRTKParatek Pharmaceuticals, Inc.Haskel William M.SVP, Sec., GCS - Sale$12.70-3,36169,597-5%-$42,685
2018-04-09
PRTKParatek Pharmaceuticals, Inc.Pagan Douglas W.CFOS - Sale$12.70-5,23777,083-6%-$66,510
2018-04-09
PRTKParatek Pharmaceuticals, Inc.Woodrow AdamVP, Chief Commercial OfficerS - Sale$12.70-5,70089,167-6%-$72,390
2018-04-09
PRTKParatek Pharmaceuticals, Inc.Loh EvanPres, COO, CMOS - Sale$12.70-8,084214,786-4%-$102,667
2018-04-09
PRTKParatek Pharmaceuticals, Inc.Bigham MichaelCOB, CEOS - Sale$12.70-8,700199,730-4%-$110,490
M
2018-04-06
AVEOAveo Pharmaceuticals IncViswanathan Ravi10%P - Purchase$2.30+920,97617,283,670+6%+$2,115,036
M
2018-04-06
AVEOAveo Pharmaceuticals IncSonsini Peter W.10%P - Purchase$2.30+920,97617,283,670+6%+$2,115,036
M
2018-04-06
AVEOAveo Pharmaceuticals IncSandell Scott D10%P - Purchase$2.30+920,97617,283,670+6%+$2,115,036
M
2018-04-06
AVEOAveo Pharmaceuticals IncSakoda Jon10%P - Purchase$2.30+920,97617,283,670+6%+$2,115,036
M
2018-04-06
AVEOAveo Pharmaceuticals IncMott David M10%P - Purchase$2.30+920,97617,283,670+6%+$2,115,036
M
2018-04-06
AVEOAveo Pharmaceuticals IncMakower Joshua10%P - Purchase$2.30+920,97617,283,670+6%+$2,115,036
M
2018-04-06
AVEOAveo Pharmaceuticals IncFlorence Anthony A. Jr.10%P - Purchase$2.30+920,97617,283,670+6%+$2,115,036
M
2018-04-06
AVEOAveo Pharmaceuticals IncBaskett Forest10%P - Purchase$2.30+920,97617,283,670+6%+$2,115,036
M
2018-04-06
AVEOAveo Pharmaceuticals IncBarris Peter J10%P - Purchase$2.30+920,97617,283,670+6%+$2,115,036
M
2018-04-06
AVEOAveo Pharmaceuticals IncGrowth Equity Opportunities Iv, LLC10%P - Purchase$2.30+920,97617,283,670+6%+$2,115,036
M
2018-04-09
AMARAmarillo Biosciences IncChen Stephen TPres, CEO, COB, 10%P - Purchase$0.18+4,0005,455,7410%+$735

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top